- Home
- OBIO vs MTC Comparison
OBIO vs MTC Comparison
Compare OBIO & MTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- MTC
- Stock Information
- Founded
- OBIO 2017
- MTC 2015
- Country
- OBIO United States
- MTC Hong Kong
- Employees
- OBIO N/A
- MTC N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- MTC Computer Software: Prepackaged Software
- Sector
- OBIO Health Care
- MTC Technology
- Exchange
- OBIO Nasdaq
- MTC Nasdaq
- Market Cap
- OBIO 156.6M
- MTC 152.7M
- IPO Year
- OBIO N/A
- MTC 2019
- Fundamental
- Price
- OBIO $5.28
- MTC $1.52
- Analyst Decision
- OBIO Strong Buy
- MTC
- Analyst Count
- OBIO 5
- MTC 0
- Target Price
- OBIO $15.80
- MTC N/A
- AVG Volume (30 Days)
- OBIO 182.8K
- MTC 289.8K
- Earning Date
- OBIO 11-12-2024
- MTC 01-28-2025
- Dividend Yield
- OBIO N/A
- MTC N/A
- EPS Growth
- OBIO N/A
- MTC N/A
- EPS
- OBIO N/A
- MTC 1.16
- Revenue
- OBIO $2,647,000.00
- MTC N/A
- Revenue This Year
- OBIO $22.61
- MTC N/A
- Revenue Next Year
- OBIO $16.64
- MTC N/A
- P/E Ratio
- OBIO N/A
- MTC $1.52
- Revenue Growth
- OBIO N/A
- MTC N/A
- 52 Week Low
- OBIO $3.96
- MTC $0.18
- 52 Week High
- OBIO $10.06
- MTC $12.90
- Technical
- Relative Strength Index (RSI)
- OBIO 50.69
- MTC 61.49
- Support Level
- OBIO $5.00
- MTC $1.32
- Resistance Level
- OBIO $5.70
- MTC $1.90
- Average True Range (ATR)
- OBIO 0.57
- MTC 0.19
- MACD
- OBIO 0.05
- MTC -0.05
- Stochastic Oscillator
- OBIO 56.41
- MTC 34.48
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About MTC MMTec Inc.
MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. It offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future, MMBD Advisory and HC Securities, and MM Global. It generates maximum revenue from the Gujia segment. Gujia segment provides market data services and investor relations management services to customers in China.